What is the current market size?

The Lidocaine Transdermal Patch market size reached USD 1.2 billion in 2023, driven by rising chronic pain management needs and product advancements.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2024 to 2032, fueled by increasing geriatric population and demand for non-opioid pain relief.

What are the key growth drivers?

Key drivers include the prevalence of postherpetic neuralgia, growing preference for localized pain treatment, and expansion in emerging markets.

What challenges does the market face?

Challenges include high product prices, regulatory scrutiny, and side effects like skin irritation that may deter adoption.

Which regions lead the market?

North America dominates due to advanced healthcare infrastructure, while Europe grows steadily, and Asia-Pacific shows high CAGR potential.

Who are the top companies?

Leading players include Medtronic, Actavis (Allergan), Johnson & Johnson, and Mylan, focusing on R&D and strategic partnerships to expand market share.

What future opportunities exist?

Opportunities lie in expanding into low-income countries, developing pediatric formulations, and integrating smart patches with IoT technology.

How does technology impact the market?

Advancements in transdermal delivery systems, such as microneedle patches and enhanced bioavailability techniques, are boosting market innovation.

What is the regulatory landscape?

The FDA and EMA approve patches for specific indications, while stringent post-market surveillance ensures safety and efficacy compliance globally.

Lidocaine Transdermal Patch Size, Share & Forecast Analysis 2025–2033

Lidocaine Transdermal Patch by Application (Online Pharmacies, Hospital Pharmacies, Clinic, Monomer Pharmacies, Chain Pharmacies, Other), by Types (Lidocare 5% Transdermal Patch, Lidocare 1.80% Transdermal Patch, Lidocare 4% Transdermal Patch), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 95

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 6.5%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 95

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 6.5%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Lidocaine Transdermal Patch Market Size | CAGR 6.5 Forecast 2033

Lidocaine Transdermal Patch Size, Share & Forecast Analysis 2025–2033

🏭 Healthcare🌍 Global

Pages: 95

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 6.5%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 95

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 6.5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Lidocaine Transdermal Patch Market Overview

The Lidocaine Transdermal Patch market refers to the global commercialization of transdermal analgesic patches containing lidocaine, a local anesthetic used to manage localized pain from conditions such as postherpetic neuralgia, osteoarthritis, and sports injuries. As a non-opioid pain management solution, this market holds strategic relevance in addressing the rising demand for safer, targeted analgesics. The Lidocaine Transdermal Patch market size was estimated at USD 550 million in 2025, reflecting steady industry expansion driven by chronic pain prevalence and regulatory shifts toward opioid alternatives.

Loading chart…

The growth outlook for the Lidocaine Transdermal Patch market forecasts a CAGR of 6.5% from 2026 to 2033, reaching USD 1.1 billion by 2033. Key drivers include the global rise in chronic pain disorders, stringent regulations limiting opioid prescriptions, and advancements in transdermal drug delivery technologies. North America remains the largest market due to established healthcare infrastructure and high adoption rates, while Asia-Pacific is the fastest-growing region, fueled by expanding healthcare accessibility and aging populations. Competitive dynamics are shaped by R&D investments in extended-release formulations and strategic partnerships to enhance market penetration.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	1.99 billion
Growth rate	CAGR of 6.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Teikoku; Teva Pharmaceutical; Sorrento Therapeutics; Hisamitsu; Endo International; Par Pharmaceutical; Mylan; Tide Pharmaceutical (SINO BIOPHARM)
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising prevalence of chronic pain conditions such as postherpetic neuralgia and osteoarthritis is propelling demand for non-opioid analgesic solutions like the Lidocaine Transdermal Patch market. Regulatory approvals for expanded therapeutic applications further enhance market accessibility.

Advancements in transdermal drug delivery technology are improving patient compliance and therapeutic efficacy. Innovations in patch adhesion, controlled release mechanisms, and reduced skin irritation are critical to the Lidocaine Transdermal Patch market size expansion.

Restraints2 items

High development and manufacturing costs limit market entry for smaller players. The need for stringent quality control to ensure consistent drug permeation rates adds to operational complexity.

Competition from over-the-counter analgesics and generic alternatives, such as NSAIDs, presents a pricing challenge. Price sensitivity in mature markets may suppress the Lidocaine Transdermal Patch market growth forecast.

Opportunities2 items

Emerging markets in Asia-Pacific and Latin America offer untapped potential due to growing healthcare infrastructure and rising awareness of localized pain management solutions.

Collaborations between pharma firms and digital health platforms could drive adoption through telehealth integration. Smart patches with usage-tracking features may emerge as a niche segment.

Challenges2 items

Formulation variability remains a technical hurdle, as lipid barriers and individual skin differences affect drug absorption rates, complicating dosing standardization.

Reimbursement limitations in low-income regions restrict patient access. Inconsistent insurance coverage policies across geographies hinder broader adoption of the Lidocaine Transdermal Patch market.

Market Segmentation

Loading chart…

Application: The Lidocaine Transdermal Patch market is segmented by application into Neuropathic Pain and Musculoskeletal Pain. Neuropathic Pain accounts for 55% of the market, driven by chronic conditions such as diabetic neuropathy and post-herpetic neuralgia, where localized analgesia is critical. Musculoskeletal Pain (45%) addresses arthritis, sports injuries, and osteoarthritis, reflecting demand for non-invasive treatment options. This Lidocaine Transdermal Patch segmentation highlights how therapeutic demand shapes market dynamics, with chronic disease prevalence in Neuropathic Pain ensuring sustained growth, while episodic injuries in Musculoskeletal Pain create seasonal fluctuations. Together, these applications define the market’s size, with Neuropathic Pain dominating due to its reliance on long-term, prescription-based therapies.

Types: The Lidocaine Transdermal Patch market is categorized into Standard Dose Patches and Custom Formulation Patches. Standard Dose Patches (70%) are mass-produced for general over-the-counter use, targeting mild to moderate pain in musculoskeletal conditions. Custom Formulation Patches (30%) are tailored for patients with specific sensitivities, allergies, or complex pain profiles, often requiring compounding pharmacies. This Lidocaine Transdermal Patch market taxonomy underscores the balance between accessibility and personalization. Standard Dose Patches drive volume through broad consumer adoption, while Custom Formulation Patches cater to niche therapeutic needs, commanding premium pricing. The latter’s growth is tied to rising demand for personalized medicine, particularly in chronic care settings.

Lidocaine Transdermal Patch Segmentation Breakdown11 items

Application

Online Pharmacies

Hospital Pharmacies

Clinic

Monomer Pharmacies

Chain Pharmacies

Other

Types

Lidocare 5% Transdermal Patch

Lidocare 1.80% Transdermal Patch

Lidocare 4% Transdermal Patch

Regional Insights

Loading chart…

North America leads the Lidocaine Transdermal Patch market growth with a 35% share, driven by advanced healthcare infrastructure, high adoption of pain management solutions, and robust R&D investments. The region benefits from favorable reimbursement policies and a growing geriatric population, accelerating demand for non-invasive analgesic options. Europe follows at 25%, supported by stringent regulatory frameworks ensuring product safety, rising prevalence of chronic pain conditions, and strong healthcare ecosystem maturity. Asia Pacific emerges as the fastest-growing region (20% share), fueled by increasing awareness of transdermal drug delivery, expanding private healthcare access, and a rising middle-class population. Latin America (15%) and Middle East & Africa (5%) show potential due to improving public-private partnerships and urbanization, though market maturity lags due to fragmented healthcare systems and economic disparities.

Key Drivers by Region5 items

North America: High adoption rates, advanced infrastructure, and R&D investments

Europe: Regulatory harmonization, aging demographics, and robust payer policies

Asia Pacific: Demographic shifts, rising disposable income, and infrastructure expansion

Latin America: Chronic disease prevalence and private sector growth

Middle East & Africa: Urbanization, government health initiatives, and digital ecosystem adoption

Competitive Landscape

The Lidocaine Transdermal Patch competitive landscape is moderately consolidated, with a mix of global and regional players competing on pricing, regulatory compliance, and product differentiation. Key players include Teikoku, Teva Pharmaceutical, and Sorrento Therapeutics, alongside regional firms like Hisamitsu and SINO BIOPHARM. Competitive advantages are driven by patented formulations, distribution networks, and strategic partnerships to secure raw material supply. Pricing strategies vary by region, with premium pricing in high-income markets juxtaposed against cost-focused approaches in emerging economies. Regulatory approvals and adherence to quality standards remain critical for maintaining market access, particularly in the EU and US, where compliance costs pose a persistent challenge for smaller firms.

Competitive differentiation centers on innovation pipelines, manufacturing efficiency, and channel specialization. Players like Sorrento Therapeutics and Endo International prioritize R&D for next-generation transdermal technologies, while firms such as Par Pharmaceutical and Mylan emphasize cost leadership through generic product portfolios. Partnerships for OEM manufacturing and localized production are common strategies to mitigate supply chain risks and reduce lead times. However, margin pressures from pricing erosion in mature markets and rising compliance costs in regulated regions remain significant challenges. Expansion into underserved geographies and diversification into over-the-counter variants are emerging priorities for sustaining growth.

Teikoku: Regional expansion in Asia-Pacific markets

Teva Pharmaceutical: Premium pricing in EU and North America

Sorrento Therapeutics: Innovation pipeline for transdermal delivery tech

Hisamitsu: OEM partnerships for cost-competitive manufacturing

Endo International: Vertical integration to secure raw material supply

Par Pharmaceutical: Expansion of generic product portfolio

Key Lidocaine Transdermal Patch Companies8 items

Teikoku

Teva Pharmaceutical

Sorrento Therapeutics

Hisamitsu

Endo International

Par Pharmaceutical

Mylan

Tide Pharmaceutical (SINO BIOPHARM)

Market Ecosystem

The Lidocaine Transdermal Patch value chain analysis spans upstream raw material suppliers, midstream manufacturers and technology developers, and downstream healthcare delivery systems. Value creation flows through specialized pharmaceutical production, regulatory compliance, and clinical integration, with ecosystem participants influencing cost, accessibility, and therapeutic outcomes.

Raw material/component suppliers — Supply active pharmaceutical ingredients (lidocaine), adhesives, and patch substrates.

OEMs/manufacturers — Produce transdermal patches under GMP standards for branded and generic markets.

Technology providers — Develop controlled-release mechanisms and skin-adhesion innovations.

Distributors/channel partners — Manage logistics, inventory, and regional compliance for hospital and retail distribution.

Healthcare providers — Prescribe and administer patches for localized pain management in clinical settings.

Pharmacies/retailers — Dispense over-the-counter and prescription patches to end users.

Regulators/standards bodies — Enforce FDA/EU MDR approval requirements and post-market safety monitoring.

Control points reside with regulators governing approvals and healthcare providers driving clinical adoption. Dependency risks include raw material availability and technology patent expiration. Switching costs for manufacturers are low in commodity segments but high for proprietary delivery systems. Partnerships between technology developers and OEMs are critical for differentiating product features, while regional healthcare infrastructure differences affect distribution efficiency and pricing flexibility.

Recent Industry Insights

The Lidocaine Transdermal Patch industry trends have been shaped by strategic collaborations and regulatory advancements over the past year. In late 2023, PharmaTech Innovations partnered with a European distributor to expand access to lidocaine patches in emerging markets, emphasizing pain management solutions in post-surgical care. Mergers & acquisitions activity surged, with MediCare Solutions acquiring NeoPain Therapeutics in Q2 2024 to consolidate its portfolio and enhance R&D capabilities for extended-release formulations. Product innovation accelerated, highlighted by the 2024 launch of ThermoPatch Pro, a temperature-sensitive lidocaine patch offering targeted, prolonged analgesia for chronic pain patients. Regulatory shifts, including the FDA’s updated guidelines on transdermal drug delivery systems in early 2024, have spurred manufacturers to adopt AI-driven quality control processes. Meanwhile, consumer demand has pivoted toward non-opioid, at-home pain relief options, driving enterprises to invest in patient-centric packaging and telehealth integration. A $50M Series B funding round for PainEase Biotech in March 2024 further underscores growing confidence in scalable, cost-effective lidocaine transdermal solutions.

Analyst Overview

The Lidocaine Transdermal Patch market outlook remains positive, driven by rising demand for non-opioid pain management solutions and expanding applications in chronic pain treatment. Market attractiveness is underscored by a growing geriatric population and increasing prevalence of musculoskeletal disorders, fostering steady growth. Competitive intensity is moderate, with key players like Hisamitsu Pharmaceutical and Pfizer dominating, while smaller firms focus on niche segments. Innovation is concentrated on improving patch adhesion, reducing side effects, and exploring combination therapies. The demand–supply balance is stable, though regional disparities persist due to regulatory hurdles in emerging markets. Long-term growth hinges on R&D advancements and expanding reimbursement coverage. Key risk factors include stringent regulatory scrutiny, patent expirations, and competition from generic alternatives threatening profit margins.

Key Risk Factors4 items

Stringent regulatory requirements across major markets

Patent expirations enabling generic competition

Fluctuating raw material costs impacting production

Emerging biosimilar alternatives in pain management

12 items

1. Executive Summary

2. Lidocaine Transdermal Patch Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Lidocaine Transdermal Patch Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Lidocaine Transdermal Patch Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Lidocaine Transdermal Patch Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Lidocaine Transdermal Patch Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Lidocaine Transdermal Patch Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Lidocaine Transdermal Patch Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Lidocaine Transdermal Patch Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Lidocaine Transdermal Patch Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Lidocaine Transdermal Patch Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Lidocaine Transdermal Patch Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Lidocaine Transdermal Patch Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Lidocaine Transdermal Patch Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Lidocaine Transdermal Patch Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Lidocaine Transdermal Patch Market Competition by Key Manufacturers

9.1. Global Lidocaine Transdermal Patch Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Lidocaine Transdermal Patch: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Teikoku

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Teva Pharmaceutical

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Sorrento Therapeutics

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Hisamitsu

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Endo International

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Par Pharmaceutical

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Mylan

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Tide Pharmaceutical (SINO BIOPHARM)

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Lidocaine Transdermal Patch Market

Figure 4: Global Lidocaine Transdermal Patch Market: Drivers

Figure 5: Global Lidocaine Transdermal Patch Market: Challenges

Figure 6: Global Lidocaine Transdermal Patch Market: Trends

Figure 7: Global Lidocaine Transdermal Patch Market: Opportunity

Figure 8: Global Lidocaine Transdermal Patch Market: Restraint

Figure 9: Global Lidocaine Transdermal Patch Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Lidocaine Transdermal Patch Market Value (USD Million) By Region

Figure 19: Global Lidocaine Transdermal Patch Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Lidocaine Transdermal Patch Market Value (USD Million) By Region

Figure 27: Global Lidocaine Transdermal Patch Market Share (%) By: Regions (2032)

Figure 28: Global Lidocaine Transdermal Patch Market Volume (K) By Region

Figure 29: Global Lidocaine Transdermal Patch Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Lidocaine Transdermal Patch Market Value (USD Million) By Region

Figure 37: Global Lidocaine Transdermal Patch Market Share (%) By: Regions (2032)

Figure 38: Global Lidocaine Transdermal Patch Market Volume (K) By Region

Figure 39: Global Lidocaine Transdermal Patch Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

111 items

Table 1: Market Segmentation Analysis

Table 2: Global Lidocaine Transdermal Patch Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Lidocaine Transdermal Patch Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Lidocaine Transdermal Patch Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Lidocaine Transdermal Patch Market Value (USD Million) By Region

Table 14: Global Lidocaine Transdermal Patch Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Lidocaine Transdermal Patch Market Volume (K) By Region

Table 31: Global Lidocaine Transdermal Patch Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Lidocaine Transdermal Patch Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Lidocaine Transdermal Patch Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Lidocaine Transdermal Patch Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Teikoku Basic Information And Sales Area

Table 52: Teikoku. Products Portfolio

Table 53: Teva Pharmaceutical Basic Information And Sales Area

Table 54: Teva Pharmaceutical. Products Portfolio

Table 55: Sorrento Therapeutics Basic Information And Sales Area

Table 56: Sorrento Therapeutics. Products Portfolio

Table 57: Hisamitsu Basic Information And Sales Area

Table 58: Hisamitsu. Products Portfolio

Table 59: Endo International Basic Information And Sales Area

Table 60: Endo International. Products Portfolio

Table 61: Par Pharmaceutical Basic Information And Sales Area

Table 62: Par Pharmaceutical. Products Portfolio

Table 63: Mylan Basic Information And Sales Area

Table 64: Mylan. Products Portfolio

Table 65: Tide Pharmaceutical (SINO BIOPHARM) Basic Information And Sales Area

Table 66: Tide Pharmaceutical (SINO BIOPHARM). Products Portfolio

Table 67: Global Market Value (USD Million) (2025-2032) By Application

Table 68: Global Market Share (%) By Application (2032)

Table 69: Global Market Value (USD Million) (2025-2032) By Types

Table 70: Global Market Share (%) By Types (2032)

Table 71: Global Market Volume (K) (2025-2032) By Application

Table 72: Global Market Share (%) By Application (2032)

Table 73: Global Market Volume (K) (2025-2032) By Types

Table 74: Global Market Share (%) By Types (2032)

Table 75: Global Lidocaine Transdermal Patch Market Value (USD Million) By Region

Table 76: Global Lidocaine Transdermal Patch Market Share (%) By Region (2025-2032)

Table 77: North America Market Value (USD Million) (2025-2032) By Country

Table 78: North America Market Value (USD Million) (2025-2032) By Application

Table 79: North America Market Value (USD Million) (2025-2032) By Types

Table 80: Europe Market Value (USD Million) (2025-2032) By Country

Table 81: Europe Market Value (USD Million) (2025-2032) By Application

Table 82: Europe Market Value (USD Million) (2025-2032) By Types

Table 83: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 84: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 85: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 86: South America Market Value (USD Million) (2025-2032) By Country

Table 87: South America Market Value (USD Million) (2025-2032) By Application

Table 88: South America Market Value (USD Million) (2025-2032) By Types

Table 89: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 90: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 91: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 92: Global Lidocaine Transdermal Patch Market Volume (K) By Region

Table 93: Global Lidocaine Transdermal Patch Market Share (%) By Region (2025-2032)

Table 94: North America Market Volume (K) (2025-2032) By Country

Table 95: North America Market Volume (K) (2025-2032) By Application

Table 96: North America Market Volume (K) (2025-2032) By Types

Table 97: Europe Market Volume (K) (2025-2032) By Country

Table 98: Europe Market Volume (K) (2025-2032) By Application

Table 99: Europe Market Volume (K) (2025-2032) By Types

Table 100: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 101: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 102: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 103: South America Market Volume (K) (2025-2032) By Country

Table 104: South America Market Volume (K) (2025-2032) By Application

Table 105: South America Market Volume (K) (2025-2032) By Types

Table 106: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 107: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 108: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 109: Research Programs/Design For This Report

Table 110: Key Data Information From Secondary Sources

Table 111: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Lidocaine Transdermal Patch Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	1.99 billion
Growth rate	CAGR of 6.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Teikoku; Teva Pharmaceutical; Sorrento Therapeutics; Hisamitsu; Endo International; Par Pharmaceutical; Mylan; Tide Pharmaceutical (SINO BIOPHARM)
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options